Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mixed trial results for Lilly’s headache drug galcanezumab

pharmatimesJuly 13, 2018

Tag: episodic cluster headache , Galcanezumab , chronic cluster headache

PharmaSources Customer Service